SCHEMBL1104807

SCHEMBL1104807

c1ccc2c(c1)ccn1ccnc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.46
MAPT P10636 3/20 0.44
ALDH1A1 P00352 3/20 0.44
RAB9A P51151 2/20 0.44
BLM P54132 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 2/20 0.42
NPC1 O15118 2/20 0.42
KMT2A Q03164 2/20 0.42
NUDT1 P36639 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
TP53 P04637 1/20 0.42
HPGD P15428 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP2A6 P11509 2/20 0.39
F12 P00748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30595067 1.00 IDO1 (0.46) IDO1MAPTALDH1A1RAB9ABLM
SCHEMBL9128666 0.85 IDO1 (0.41) IDO1MAPTALDH1A1RAB9ABLM
SCHEMBL8134553 0.82 IDO1 (0.50) IDO1MAPTALDH1A1RAB9ABLM
SCHEMBL23533731 0.76 CYP3A4 (0.37) IDO1MAPTALDH1A1RAB9ABLM
SCHEMBL29847372 0.76 CYP3A4 (0.37) IDO1MAPTALDH1A1RAB9ABLM
SCHEMBL11212810 0.74 ALDH1A1 (0.46) MAPTALDH1A1RAB9ABLML3MBTL1
SCHEMBL1369794 0.74 LMNA (0.50) MAPTL3MBTL1LMNANUDT1KDM4E
SCHEMBL11664265 0.74 ALDH1A1 (0.46) IDO1MAPTALDH1A1RAB9ABLM
SCHEMBL30119859 0.74 MAPT (0.50) MAPTBLMLMNAKMT2ANUDT1
SCHEMBL1370432 0.74 MAPT (0.50) MAPTBLMLMNAKMT2ANUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2870140-A1 TETRAHYDROQUINAZOLINONE DERIVATIVES AS PARP INHIBITORS Lupin Limited (IN) 2015-05-13 EP claimed
WO-2014009872-A1 TETRAHYDROQUINAZOLINONE DERIVATIVES AS PARP INHIBITORS LUPIN LIMITED (IN) 2014-01-16 WO claimed
US-20030144263-A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them SYNGENTA LIMITED (GB) 2003-07-31 US claimed
JP-2073016-A None JP disclosed
CN-110698485-B Compound and application thereof 北京鼎材科技有限公司 2025-03-04 CN disclosed
CN-110698485-B Compound and application thereof 北京鼎材科技有限公司 2025-03-04 CN disclosed
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-20230242556-A1 NOVEL METHOD FOR MANUFACTURING DEUTERATED BORON COMPOUND SFC CO., LTD. (KR) 2023-08-03 US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 US disclosed
US-11672172-B2 Heterocyclic compound comprising aromatic amine group and organic light-emitting diode including the same SFC CO., LTD. (KR) 2023-06-06 US disclosed
US-11649430-B2 Method to induce spore germination in fungi WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2023-05-16 US disclosed
US-4101553-A Imidazo[2,1-a]isoquinolines SANDOZ, INC. (US) 1978-07-18 US disclosed
US-4101553-A Imidazo[2,1-a]isoquinolines SANDOZ, INC. (US) 1978-07-18 US disclosed
US-4101553-A Imidazo[2,1-a]isoquinolines SANDOZ, INC. (US) 1978-07-18 US disclosed
US-4100165-A Imidazo [2,1-a]isoquinolines SANDOZ, INC. (US) 1978-07-11 US disclosed
US-4100165-A Imidazo [2,1-a]isoquinolines SANDOZ, INC. (US) 1978-07-11 US disclosed
US-4093616-A PYRROLO(1,2-A)PYRAZINIUM, PYRAZOLO(1,5-A)PYRIDINIUM, 1H-IMIDAZO(2,1-A)ISOQUINOLINIUM, OR IMIDAZO(5,1-A)ISOQUINOLINIUM SALTS PFIZER INC. (US) 1978-06-06 US disclosed
US-4093616-A PYRROLO(1,2-A)PYRAZINIUM, PYRAZOLO(1,5-A)PYRIDINIUM, 1H-IMIDAZO(2,1-A)ISOQUINOLINIUM, OR IMIDAZO(5,1-A)ISOQUINOLINIUM SALTS PFIZER INC. (US) 1978-06-06 US disclosed
US-4044015-A Imidazopyridinium compounds as hypoglycemic agents PFIZER INC. (US) 1977-08-23 US disclosed
US-4044015-A Imidazopyridinium compounds as hypoglycemic agents PFIZER INC. (US) 1977-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144263-A1 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them CYP3A5, CYP2D6, OXA1L IDO1 1888/4885MAPT 4796/4885ALDH1A1 3134/4885
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 IDO1 3171/4885MAPT 611/4885ALDH1A1 865/4885
US-11649430-B2 Method to induce spore germination in fungi ERG28, ETF1, DPM1 IDO1 863/4885MAPT 3135/4885ALDH1A1 3690/4885
US-20230242556-A1 NOVEL METHOD FOR MANUFACTURING DEUTERATED BORON COMPOUND BCL6B, BRD7, DBF4 IDO1 2007/4885MAPT 1321/4885ALDH1A1 3057/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 IDO1 2433/4885MAPT 1713/4885ALDH1A1 125/4885
US-11672172-B2 Heterocyclic compound comprising aromatic amine group and organic light-emitting diode including the same DDC, TYR, AOC2 IDO1 120/4885MAPT 241/4885ALDH1A1 208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.